Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1. A second...
Saved in:
Main Authors: | Melissa Bowerman (Author), Catherina G. Becker (Author), Rafael J. Yáñez-Muñoz (Author), Ke Ning (Author), Matthew J. A. Wood (Author), Thomas H. Gillingwater (Author), Kevin Talbot (Author), The UK SMA Research Consortium (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Audrey M. Winkelsas, et al.
Published: (2021) -
<it>SMN1 </it>dosage analysis in spinal muscular atrophy from India
by: Leonard Debra GB, et al.
Published: (2005) -
The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
by: James N. Sleigh, et al.
Published: (2011) -
Genetic and expression studies of <it>SMN2 </it>gene in Russian patients with spinal muscular atrophy type II and III
by: Schiöth Helgi B, et al.
Published: (2011) -
Mutational analysis of SMN gene in patients with spinal muscular atrophy and the correlation between mutation and the severity of clinical manifestations
by: Almagul Nagimtaeeva, et al.
Published: (2017)